Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 41.3 HKD 0.49% Market Closed
Market Cap: 12.9B HKD
Have any thoughts about
Ascentage Pharma Group International?
Write Note

Intrinsic Value

The intrinsic value of one Ascentage Pharma Group International stock under the Base Case scenario is 58.18 HKD. Compared to the current market price of 41.3 HKD, Ascentage Pharma Group International is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
58.18 HKD
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ascentage Pharma Group International

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Ascentage Pharma Group International cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Ascentage Pharma Group International?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Ascentage Pharma Group International

Provide an overview of the primary business activities
of Ascentage Pharma Group International.

What unique competitive advantages
does Ascentage Pharma Group International hold over its rivals?

What risks and challenges
does Ascentage Pharma Group International face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascentage Pharma Group International.

Provide P/S
for Ascentage Pharma Group International.

Provide P/E
for Ascentage Pharma Group International.

Provide P/OCF
for Ascentage Pharma Group International.

Provide P/FCFE
for Ascentage Pharma Group International.

Provide P/B
for Ascentage Pharma Group International.

Provide EV/S
for Ascentage Pharma Group International.

Provide EV/GP
for Ascentage Pharma Group International.

Provide EV/EBITDA
for Ascentage Pharma Group International.

Provide EV/EBIT
for Ascentage Pharma Group International.

Provide EV/OCF
for Ascentage Pharma Group International.

Provide EV/FCFF
for Ascentage Pharma Group International.

Provide EV/IC
for Ascentage Pharma Group International.

Show me price targets
for Ascentage Pharma Group International made by professional analysts.

What are the Revenue projections
for Ascentage Pharma Group International?

How accurate were the past Revenue estimates
for Ascentage Pharma Group International?

What are the Net Income projections
for Ascentage Pharma Group International?

How accurate were the past Net Income estimates
for Ascentage Pharma Group International?

What are the EPS projections
for Ascentage Pharma Group International?

How accurate were the past EPS estimates
for Ascentage Pharma Group International?

What are the EBIT projections
for Ascentage Pharma Group International?

How accurate were the past EBIT estimates
for Ascentage Pharma Group International?

Compare the revenue forecasts
for Ascentage Pharma Group International with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascentage Pharma Group International and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascentage Pharma Group International against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascentage Pharma Group International compared to its peers.

Compare the P/E ratios
of Ascentage Pharma Group International against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascentage Pharma Group International with its peers.

Analyze the financial leverage
of Ascentage Pharma Group International compared to its main competitors.

Show all profitability ratios
for Ascentage Pharma Group International.

Provide ROE
for Ascentage Pharma Group International.

Provide ROA
for Ascentage Pharma Group International.

Provide ROIC
for Ascentage Pharma Group International.

Provide ROCE
for Ascentage Pharma Group International.

Provide Gross Margin
for Ascentage Pharma Group International.

Provide Operating Margin
for Ascentage Pharma Group International.

Provide Net Margin
for Ascentage Pharma Group International.

Provide FCF Margin
for Ascentage Pharma Group International.

Show all solvency ratios
for Ascentage Pharma Group International.

Provide D/E Ratio
for Ascentage Pharma Group International.

Provide D/A Ratio
for Ascentage Pharma Group International.

Provide Interest Coverage Ratio
for Ascentage Pharma Group International.

Provide Altman Z-Score Ratio
for Ascentage Pharma Group International.

Provide Quick Ratio
for Ascentage Pharma Group International.

Provide Current Ratio
for Ascentage Pharma Group International.

Provide Cash Ratio
for Ascentage Pharma Group International.

What is the historical Revenue growth
over the last 5 years for Ascentage Pharma Group International?

What is the historical Net Income growth
over the last 5 years for Ascentage Pharma Group International?

What is the current Free Cash Flow
of Ascentage Pharma Group International?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascentage Pharma Group International.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ascentage Pharma Group International

Current Assets 2B
Cash & Short-Term Investments 1.1B
Receivables 743.5m
Other Current Assets 120m
Non-Current Assets 1.1B
Long-Term Investments 33.2m
PP&E 931.2m
Intangibles 104.5m
Other Non-Current Assets 74.4m
Current Liabilities 1.1B
Accounts Payable 83.1m
Short-Term Debt 120m
Other Current Liabilities 862.3m
Non-Current Liabilities 1.3B
Long-Term Debt 970.6m
Other Non-Current Liabilities 304.8m
Efficiency

Earnings Waterfall
Ascentage Pharma Group International

Revenue
903m CNY
Cost of Revenue
-27.4m CNY
Gross Profit
875.6m CNY
Operating Expenses
-1.2B CNY
Operating Income
-329.9m CNY
Other Expenses
-30.4m CNY
Net Income
-360.3m CNY

Free Cash Flow Analysis
Ascentage Pharma Group International

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ascentage Pharma Group International's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
38/100
Profitability
Score

Ascentage Pharma Group International's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ascentage Pharma Group International's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
31/100
Solvency
Score

Ascentage Pharma Group International's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 48.96 HKD with a low forecast of 41.41 HKD and a high forecast of 57.75 HKD.

Lowest
Price Target
41.41 HKD
0% Upside
Average
Price Target
48.96 HKD
19% Upside
Highest
Price Target
57.75 HKD
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Ascentage Pharma Group International?

Click here to dive deeper.

Dividends

Ascentage Pharma Group International
does not pay dividends
Shareholder Yield

Current shareholder yield for Ascentage Pharma Group International is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Ascentage Pharma Group International Logo
Ascentage Pharma Group International

Country

China

Industry

Biotechnology

Market Cap

13B HKD

Dividend Yield

0%

Description

Ascentage Pharma Group International Co., Ltd. develops and produces pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 613 full-time employees. The company went IPO on 2019-10-28. The firm focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The firm's main products include the next-generation kinase inhibitor: HQP1351 and apoptosis targeted drugs APG-1252, APG2575, APG-115 and so on. The firm conducts businesses within the domestic market and to overseas markets, including the United States.

Contact

JIANGSU
Suzhou
7th Floor, Building B7, 218 Xinghu Street, Suzhou Industrial Park
www.ascentagepharma.com

IPO

2019-10-28 00:00:00

Employees

613

Officers

Co-Founder, Chairman & CEO
Dr. Dajun Yang M.D., Ph.D.
Co-Founder, Chief Scientific Advisor & Non-Executive Director
Dr. Shaomeng Wang Ph.D.
Co-Founder
Dr. Ming Guo
Senior VP & General Counsel
Mr. Thomas Knapp
Chief Medical Officer
Dr. Yifan Zhai M.D., Ph.D.
Senior Vice President of Preclinical Development
Douglas Dong Fang
Show More
Senior Vice President of Pharmaceutical Science
Jianfeng Wen
Chief Business Officer
Mr. Raymond Kmetz
Chief Commercial Officer
Mr. Yifei Zhu
Company Secretary
Mr. Cheung Ki Wong A.C.I.S., A.C.S., FCPA
Show Less

See Also

Discover More
What is the Intrinsic Value of one Ascentage Pharma Group International stock?

The intrinsic value of one Ascentage Pharma Group International stock under the Base Case scenario is 58.18 HKD.

Is Ascentage Pharma Group International stock undervalued or overvalued?

Compared to the current market price of 41.3 HKD, Ascentage Pharma Group International is Undervalued by 29%.

Back to Top